Phase
Condition
Tinnitus
Deafness
Hearing Loss
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria :
Age > 18
Social security affiliation
Permanent, non-fluctuation, high pitch, bilateral or assimilated, tinnitus
Mean value of the VAS at least at 6 between the intensity and the disturbance criteriaat the recruitment interview.
THI score superior or equal to 40 at the recruitment interview
Written consent to the protocol
Associated hearing-loss characterized by :
mean value of the hearing threshold loss for the 250, 500 and 1000 Hz thresholdsstrictly under 25 dB (deciBel).
at least one hearing threshold among the 2000, 4000, 6000 and 8000 Hz with at least 30dB of hearing loss.
mean value of the hearing threshold loss for the 2000, 4000, 6000 and 8000 Hzthresholds strictly under 70 dB.
Exclusion
Exclusion Criteria:
Subjects under legal protection (guardianship, trusteeship or judicial protection)
Notable cognitive disability impeding to understanding or performing the cognitivetasks
Meniere's disease, chronic or serous otitis, acoustic neuroma
Pulsatile tinnitus, somatosensorial tinnitus
Epilepsy
No antidepressant or anti-epileptic drug treatment
DET (DETresse) questionnaire (measure of tinnitus associated distress) above or equalto 40
Use of a sound generator during the therapy
Pregnancy or breastfeeding
Inability to wear the electrodes headset of the neuro-feedback device
Study Design
Study Description
Connect with a study center
Audika Research Center
Paris, Ile De France 75005
FranceActive - Recruiting
Purpan University hospital
Toulouse, Languedoc-Roussillon-Midi-Pyrénées 31300
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.